Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The Association Between Hormonal Contraceptive Use and Glaucoma in Women of Reproductive Age Publisher Pubmed



Hogden K1 ; Mikelberg F1 ; Sodhi M1 ; Khosrowkhavar F2 ; Mansournia MA3 ; Kezouh A2 ; Etminan M4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Ophthalmology and Visual Sciences, Faculty of Medicine, University of British Columbia, Vancouver, Canada
  2. 2. Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Canada
  3. 3. Department of Epidemiology, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Departments of Ophthalmology and Visual Sciences, Medicine and Pharmacology, University of British Columbia, Vancouver, Canada

Source: British Journal of Clinical Pharmacology Published:2021


Abstract

Aims: We aimed to investigate the association between hormonal contraceptive (HC) use and the incidence of glaucoma in females of reproductive age with a focus on duration and type of HCs used. Methods: A retrospective cohort study with a case–control analysis (nested case–control) was undertaken using data from IQVIA's electronic medical record (IQVIA, USA) from 2008 to 2018. Within a cohort of 4 871 504 women, cases of glaucoma or ocular hypertension were identified. Subjects were followed to the first diagnosis of glaucoma. Each glaucoma case was matched to four controls by age, body mass index and follow up time. The main outcome measure was the first diagnosis of glaucoma defined by the first ICD-9/10 code for glaucoma or ocular hypertension. Results: Among 4 871 504 women identified, there were 2366 cases of glaucoma and 9464 controls. Regular users of hormonal contraceptives had an elevated risk of glaucoma compared to non-users with an adjusted incident rate ratio (aIRR) of 1.57 (95% CI: 1.29–1.92). Current users were of greatest risk (aIRR of 2.38, 95% CI: 1.81–3.13), whereas the aIRR among past users was 1.08 (95% CI: 0.82–1.43). The aIRR for glaucoma increased from 0.82 (95% CI: 0.70–0.95) among those with one or two prescriptions in the 2 years prior to the first diagnosis of glaucoma to 1.54 (95% CI: 1.32–1.81) among those with greater than four prescriptions. Conclusions: This nested case–control study demonstrated an elevated risk, albeit low, of glaucoma in females of reproductive age who use regular hormonal contraception. Future studies are needed to confirm these findings. © 2021 British Pharmacological Society